Cidara Therapeutics Inc. (NASDAQ: CDTX) Stock Information | RedChip

Cidara Therapeutics Inc. (NASDAQ: CDTX) Listen to this Section


$12.50
-0.1400 ( -1.11% ) 11.7K

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Market Data


Open


$12.50

Previous close


$12.64

Volume


11.7K

Market cap


$90.02M

Day range


$12.45 - $12.83

52 week range


$10.00 - $24.40

Insider Ownership Transactions

Total Amount Purchased: -115,049.00 | $ -1,438,112.50

Date Type Amount Purchased Purchaser
2024-03-12 Sale -18931.00 Shah Preetam
2024-03-12 Sale -20662.00 Sandison Taylor
2024-03-12 Sale -21029.00 Tari Leslie
2024-03-12 Sale -56692.00 Stein Jeffrey
2024-03-12 Sale -20473.00 Ward Shane
2023-09-13 Sale -18469.00 Tari Leslie
2023-09-13 Sale -18793.00 Sandison Taylor
2023-08-14 Buy 10000.00 Tari Leslie
2023-08-08 Buy 50000.00 Stein Jeffrey

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 May 15, 2024
8-k 8K-related 77 May 03, 2024
4 Insider transactions 1 Apr 30, 2024
3 Insider transactions 1 Apr 30, 2024
4 Insider transactions 1 Apr 30, 2024
3 Insider transactions 1 Apr 30, 2024
4 Insider transactions 1 Apr 30, 2024
3 Insider transactions 1 Apr 30, 2024
4 Insider transactions 1 Apr 30, 2024
3 Insider transactions 1 Apr 30, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.